Rf. Squires et E. Saederup, CLOZAPINE AND SOME OTHER ANTIPSYCHOTIC-DRUGS MAY PREFERENTIALLY BLOCKTHE SAME SUBSET OF GABA(A) RECEPTORS, Neurochemical research, 22(2), 1997, pp. 151-162
Selective blockade of a subset of GABA(A) receptors may be involved in
the antipsychotic effects of Clozapine and several other antipsychoti
c drugs. Seven antipsychotic drugs, and 11 drugs classified as antidep
ressants that only partially reverse the inhibitory effect of 1 mu M G
ABA on [S-35]TBPS binding, do not yield additive reversal when tested
painwise with Clozapine, which also only partially reverses the inhibi
tory effect of GABA. This suggests that all of these antipsychotic/ant
idepressant drugs may block a common subset of GABA(A) receptors. DMCM
and Ro 5-4864 are also partial reversers of GABA's inhibitory effect,
but they yield additive reversals when tested pairwise with the antip
sychotic/antidepressant drugs, and also with each other, suggesting th
at DMCM, Ro 5-4864, and the antipsychotic drugs define three heterogen
eous subsets of GABA(A) receptors, with variable overlap, depending on
the drug. Several potent ligands for benzodiazepine binding sites can
block the GABA inhibitory effects of DMCM and Ro 5-4864, but with dif
ferent patterns: the ligands generally blocked DMCM less potently, but
more completely than Ro 5-4864. Ro 5-4864 was not blocked by Flumazen
il or CGS-8216, ligands that potently blocked DMCM. Nine additional an
tipsychotic/antidepressant drugs, as well as Clozapine, and 7 ''classi
cal'' GABA(A) receptor blockers, all of which reversed GABA nearly com
pletely, when tested at lower concentrations that only reverse similar
to 20-35%, yielded almost complete additivity when tested painwise wi
th DMCM or Ro 5-4864. Another convulsant benzodiazepine, KW-1937, a po
sitional isomer of Brotizolam, fully reverses the inhibitory effect of
1 mu M GABA. At a lower concentration yielding about 50% reversal, KW
-1937 is completely additive with DMCM, but entirely nonadditive with
Ro 5-4864. The 50% reversal obtained with KW-1937 was potently blocked
by Triazolam, but with a plateau similar to that obtained with Ro 5-4
864. The results with KW-1937 suggest that its 50% reversal largely co
rresponds to the reversal obtained with Ro 5-4864, and that virtually
all of the [S-35]TBPS binding sites inhibited by 1 mu M GABA are coupl
ed to benzodiazepine binding sites. The fraction of GABA(A) receptors
preferentially blocked by all the antipsychotic/antidepressant drugs,
roughly 25% of the [S-35]TBPS binding sites inhibited with 1 mu M GABA
, are sensitive to KW 1937, but not to DMCM or to Ro 5-4864.